For far too long acne has crippled the faces of society’s youths, today DermatoloMe shows how we can fight back.
You’ve tried countless over the counter topicals, different types of face and clay masks, oral antibiotic medication, and even worked on perfecting an end all skin care routine. Yet, another day passes and a new little red bump pesters itself onto your skin with it’s accomplices not far from behind. You’ve guessed it, we’re talking about the medical condition Acne vulgaris.
Many of us have battled the aggravating and persistent symptoms of acne. If you were one of the stand a lone few, congratulations for having stellar genes or a glorified skin care routine and diet. But for the rest of us, there may just be an easier solution to treating our ill invaders.
Penn State University graduate student, Austin Wittmer, founded DermatoloMe, an innovative, at-home testing product that aims to identify the optimal antibiotic treatment for patients who suffer from persistent, severe acne. In his market research conducted at Penn State, Wittmer claims that 80% of people who suffer from acne will use at least one over the counter product, and 50% will seek further consultation with a dermatologist. His hybrid product & service allows patients to bypass the time consuming and costly step of visiting the dermatologist office.
Under the directives of DermatoloMe’s at-home testing kit, patients will collect a small sample of their acne and send it back to their lab. From there, a dermatologist will isolate the bacteria responsible for the patient’s acne, identify an optimal antibiotic solution, and deliver the results back to the patient.
DermatoloMe has been showcased at Penn State University’s 2019 Venture & IP Conference Student Startup Showcase and is currently seeking funding to acquire appropriate lab space and R&D materials for the testing process. To learn more about DermatoloMe and to hear from Austin Wittmer, visit the links down below.
To learn more about DermatoloMe and their mission, watch their pitch in the link below.